π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
The purpose of the study was to evaluate the efficacy (how well the medicin...
Status
Completed
Location
Gaborone CRS (Site ID: 12701)
Start Date
2022-09-27
Trial ID
NCT05007821
This is a phase 2B, open label study, that will compare the safety and effi...
Status
Unknown
Location
TASK Applied Sciences Clinical Research Centre
Start Date
2023-09-21
Trial ID
NCT05926466
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of 26 weeks...
Status
Active Not Recruiting
Location
Gaborone CRS
Start Date
2019-06-03
Trial ID
NCT03568383
Treatments Being Tested
The proposed study will randomize adults (18 years of age or older) with pu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-08
Trial ID
NCT02975570
Treatments Being Tested
The purpose of this study is to determine whether one or two 17-week regime...
Status
Active Not Recruiting
Location
TBTC Site 26 Seattle & King County TB Control Program
Start Date
2023-11-21
Trial ID
NCT05766267
Treatments Being Tested
This study is to evaluate the effectiveness and safety of a 9-month MDR-END...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-30
Trial ID
NCT06674291
Treatments Being Tested
This trial will assess the safety and efficacy of OPC-167832 combined with ...
Status
Completed
Location
Aurum Institute - Tembisa Clinical Research Centre
Start Date
2022-04-12
Trial ID
NCT05221502
Treatments Being Tested
Multidrug-resistant tuberculosis (MDR-TB) is tuberculosis (TB) that is resi...
Status
Active Not Recruiting
Location
TB-HIV Innovations & Clinical Research Foundation Corp
Start Date
2022-06-07
Trial ID
NCT03828201
Treatments Being Tested
This study measured the early bactericidal activity (EBA), safety, tolerabi...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-07-26
Trial ID
NCT05382312
Treatments Being Tested